Follow
Suárez-Pinilla P
Suárez-Pinilla P
Médico Psiquiatra
Verified email at humv.es
Title
Cited by
Cited by
Year
Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies
F Catalá-López, M Suárez-Pinilla, P Suárez-Pinilla, JM Valderas, ...
Psychotherapy and psychosomatics 83 (2), 89-105, 2014
2152014
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset
MK Chan, MO Krebs, D Cox, PC Guest, RH Yolken, H Rahmoune, ...
Translational psychiatry 5 (7), e601-e601, 2015
1752015
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium
E Walton, DP Hibar, TGM Van Erp, SG Potkin, R Roiz-Santiañez, ...
Psychological medicine 48 (1), 82-94, 2018
1452018
Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium
E Walton, DP Hibar, TGM van Erp, SG Potkin, R Roiz‐Santiañez, ...
Acta Psychiatrica Scandinavica 135 (5), 439-447, 2017
952017
Homocysteine and cognition: A systematic review of 111 studies
E Setién-Suero, M Suárez-Pinilla, P Suárez-Pinilla, B Crespo-Facorro, ...
Neuroscience & Biobehavioral Reviews 69, 280-298, 2016
762016
Towards precision medicine in psychosis: benefits and challenges of multimodal multicenter studies—PSYSCAN: translating neuroimaging findings from research into clinical practice
S Tognin, HH van Hell, K Merritt, I Winter-van Rossum, MG Bossong, ...
Schizophrenia bulletin 46 (2), 432-441, 2020
682020
Gene-environment interactions underlying the effect of cannabis in first episode psychosis
J Maria Pelayo-Teran, P Suárez-Pinilla, N Chadi, B Crespo-Facorro
Current pharmaceutical design 18 (32), 5024-5035, 2012
682012
Immune system: a possible nexus between cannabinoids and psychosis
P Suárez-Pinilla, J López-Gil, B Crespo-Facorro
Brain, behavior, and immunity 40, 269-282, 2014
662014
Antipsychotic treatment effectiveness in first episode of psychosis: PAFIP 3-year follow-up randomized clinical trials comparing haloperidol, olanzapine, risperidone …
M Gómez-Revuelta, JM Pelayo-Terán, M Juncal-Ruiz, ...
International Journal of Neuropsychopharmacology 23 (4), 217-229, 2020
562020
Brain structural effects of antipsychotic treatment in schizophrenia: a systematic review
R Roiz-Santiañez, P Suarez-Pinilla, B Crespo-Facorro
Current neuropharmacology 13 (4), 422-434, 2015
532015
Association of insulin resistance with schizophrenia polygenic risk score and response to antipsychotic treatment
J Tomasik, SG Lago, J Vázquez-Bourgon, S Papiol, P Suárez-Pinilla, ...
JAMA psychiatry 76 (8), 864-867, 2019
512019
In-and outpatient lifestyle interventions on diet and exercise and their effect on physical and psychological health: a systematic review and meta-analysis of randomised …
B Fernández-Abascal, P Suárez-Pinilla, C Cobo-Corrales, ...
Neuroscience & Biobehavioral Reviews 125, 535-568, 2021
502021
Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study
B Crespo-Facorro, VOG de la Foz, R Ayesa-Arriola, R Pérez-Iglesias, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 44, 162-167, 2013
462013
Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis
JM Pelayo-Terán, FJ Diaz, R Pérez-Iglesias, P Suarez-Pinilla, ...
Psychological medicine 44 (1), 37-50, 2014
442014
Predictors of clinical remission following a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables
I Díaz, JM Pelayo-Terán, R Pérez-Iglesias, I Mata, R Tabarés-Seisdedos, ...
Psychiatry Research 206 (2-3), 181-187, 2013
442013
Brain structural and clinical changes after first episode psychosis: focus on cannabinoid receptor 1 polymorphisms
P Suárez-Pinilla, R Roiz-Santiañez, VOG de la Foz, PC Guest, ...
Psychiatry Research: Neuroimaging 233 (2), 112-119, 2015
412015
Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis
R Pérez-Iglesias, VOG de la Foz, OM García, JA Amado, ...
Schizophrenia research 159 (1), 90-94, 2014
412014
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment
M Juncal-Ruiz, M Ramirez-Bonilla, J Gomez-Arnau, ...
Psychopharmacology 234, 2563-2570, 2017
392017
Understanding sex differences in long-term outcomes after a first episode of psychosis
R Ayesa-Arriola, VOG de la Foz, E Setién-Suero, ML Ramírez-Bonilla, ...
Npj Schizophrenia 6 (1), 33, 2020
382020
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naive patients with a first-episode of non-affective psychosis
J Vázquez-Bourgon, R Pérez-Iglesias, V Ortiz-Garcia de la Foz, ...
Psychopharmacology 235, 245-255, 2018
372018
The system can't perform the operation now. Try again later.
Articles 1–20